Abstract:Wei Huang Jie Liu Shanbiao Hu 4 Guangqing Shi Zhong Yong Jian Li Juan Qiu Yan Cao Li Yuan 1Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 2Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 3Department of Pathology, Changsha Central Hospital, Changsha, Hunan, People’s Republic of China; 4Department of Urological Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China Background: Radioresistance is the leading cause of treatment failure for nasopharyngeal carcinoma (NPC). Therefore, screening the critical regulators in radioresistance and revealing the underlying mechanisms is imperative for improvement of therapeutical efficacy in NPC. Materials and methods: Our previous study has proved that miR-181a may serve as a proradioresistant miRNA. In this study, we explored the expression of miR-181a in NPC, especially in radioresistant NPC samples, by qPCR. Moreover, the clinical significance of miR-181a level was also analyzed. Furthermore, the functions of miR-181a, both in vitro and in vivo, were detected via a serial of assays such as CCK-8, plate clone survival, apoptosis, and xenograft tumor model. The downstream target of miR-181a was also validated by dual luciferase reporter assay and the roles of miR-181a’s target in the regulation of NPC radioresistance were investigated. Results: The results revealed that miR-181a was significantly upregulated in NPC, especially in radioresistant NPC. MiR-181a level is positively correlated to lymph node metastasis and advanced TNM stages and negatively associated with overall survival rate in NPC. Ectopic expression of miR-181a in radiosensitive NPC cells, or overexpression of miR-181a inhibitor in radioresistant NPC cells, could enhance or impair the radioresistance of NPC cells supported by the results from both in vitro and in vivo, respectively. Mechanistically, dual luciferase report assay indicated that miR-181a could directly target RKIP. Moreover, both in vitro and in vivo experimental outcomes indicated that RKIP restoration and knockdown could antagonize the effects of miR-181a and miR-181a inhibitor in the regulation of NPC radioresistance. Conclusion: Collectively, the findings of this study proved that miR-181a is upregulated and promotes radioresistance by targeting RKIP in NPC. Targeting miR-181a/RKIP axis may be a valid path for reinforcing radiosensitivity and eventually improving the outcomes of clinical treatment in NPC.

MicroRNA-613 Enhances Nasopharyngeal Carcinoma Cell Radiosensitivity via the DNA Methyltransferase 3B/ Tissue Inhibitor of Matrix Metalloproteinase-3/Signal Transducer and Activator of Transcription-1/Forkhead Box O-1 Axis

MicroRNA-19b-3p Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting TNFAIP3/NF-κB Axis

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

MiR-138-1-3p Alters the Stemness and Radiosensitivity of Tumor Cells by Targeting CRIPTO and the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma.

miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.

MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway

MicroRNA-372 Enhances Radiosensitivity While Inhibiting Cell Invasion and Metastasis in Nasopharyngeal Carcinoma Through Activating the PBK-dependent P53 Signaling Pathway

Microrna-613 Exerts Anti-Angiogenic Effect on Nasopharyngeal Carcinoma Cells Through Inactivating the AKT Signaling Pathway by Down-Regulating FN1

Ott_a_228800 10873..10884

miR‐182‐5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression

miR-128-3p increases the radiosensitivity in nasopharyngeal carcinoma via regulating vascular endothelial growth factor C

Involvement of Microrna-24 and Dna Methylation in Resistance of Nasopharyngeal Carcinoma to Ionizing Radiation

Mir-181A Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP

MicroRNA-324-3p Regulates Nasopharyngeal Carcinoma Radioresistance by Directly Targeting WNT2B.

Integrated Analysis of Differential Mirna and Mrna Expression Profiles in Human Radioresistant and Radiosensitive Nasopharyngeal Carcinoma Cells.

Inhibition of cell proliferation and radioresistance by miR-383-5p through targeting RNA binding protein motif (RBM3) in nasopharyngeal carcinoma

Mirna-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting Il8/Akt Signaling

Mir-185-3p Regulates Nasopharyngeal Carcinoma Radioresistance by Targeting WNT2B in Vitro.

Ott_a_233435 11271..11280

Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT/mTOR Axis and HSPA5-mediated Autophagy

Retraction: MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.